Sproxil: Combating Counterfeit Drugs with Mobile Phones
Sproxil joined the BCtA with a commitment to mobilize US$4 million to expand its efforts to empower patients and consumers in the fight against counterfeit medication in India and Kenya. In this BCtA case study, learn more about how the company is promoting improved health care outcomes in key markets.
Download Case Study:
Locations
Hover on a location and click to select for more information.
